BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NeoGenomics, Inc. (Acquired By American Communications Enterprises, Inc.) 

12701 Commonwealth Drive
Suite 9
Fort Myers  Florida  33913  U.S.A.
Phone: 239-768-0600 Fax: 239-768-0711


SEARCH JOBS




Industry
Biotechnology






 Company News
NeoGenomics, Inc. (NGNM.OB), The Robert H. Lurie Comprehensive Cancer Center Of Northwestern University, And The Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program 12/16/2014 8:10:50 AM
N-of-One Selected By NeoGenomics, Inc. (NGNM.OB) To Provide Clinical Evidence For Interpreting Solid Tumor Next-Generation Sequencing Tests 12/2/2014 10:10:55 AM
NeoGenomics, Inc. (NGNM.OB) Reports 38% Increase In Revenue To A Record $23.2 Million And Adjusted EBITDA Of $2.6 Million For The Third Quarter Of 2014 10/30/2014 8:11:57 AM
NeoGenomics, Inc. (NGNM.OB) Is First To Offer Molecular Testing For Resistance To Bruton Tyrosin Kinase Inhibitors For Chronic Lymphocytic Leukemia 10/23/2014 8:37:27 AM
NeoGenomics, Inc. (NGNM.OB) Launches 315 Gene Next Generation Sequencing Test For Solid Tumor Discovery Profiling 10/16/2014 7:46:00 AM
NeoGenomics, Inc. (NGNM.OB) Appoints Robert J. Shovlin As Chief Operating Officer 9/30/2014 7:57:51 AM
NeoGenomics, Inc. (NGNM.OB) Announces Closing Of Recent Equity Offering And Exercise In Full Of Underwriters' Over-Allotment Option 8/22/2014 7:43:16 AM
NeoGenomics, Inc. (NGNM.OB) Announces Public Offering Of Common Stock 8/15/2014 8:22:50 AM
NeoGenomics, Inc. (NGNM.OB) Reports Record Revenues Of $20.7 Million On 40% Test Volume Growth And Expanding Gross Margins For The Second Quarter 2014 7/17/2014 10:59:29 AM
NeoGenomics, Inc. (NGNM.OB) Expands Next Generation Sequencing Services And Offers 23 Different Profiles For Various Hematologic And Solid Cancers 7/11/2014 9:11:57 AM
12345678910...